Actinium Pharmaceuticals, Inc.
ATNM
$1.24
$0.010.81%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 605.27% | 7.04% | -15.77% | 25.40% | 56.85% |
| Total Depreciation and Amortization | 9.55% | 6.80% | 0.00% | 0.98% | -0.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -317,209.09% | 10.00% | -90.83% | -44.67% | -97.78% |
| Change in Net Operating Assets | 369.60% | -233.10% | 128.83% | -239.08% | 251.75% |
| Cash from Operations | 11.77% | -10.99% | 16.38% | -17.30% | 28.81% |
| Capital Expenditure | -23,800.00% | 98.08% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23,800.00% | 98.08% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | 0.00% | -50.00% | 33.33% | -50.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.33% | 0.00% | 98.56% | -6,866.67% | -50.00% |
| Foreign Exchange rate Adjustments | -81.82% | 83.33% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.53% | -8.79% | 17.51% | -21.11% | 28.79% |